Active Implantable Medical Devices Market Report 2026

Active Implantable Medical Devices Market Overview

• Active Implantable Medical Devices market size has reached to $27.95 billion in 2025 • Expected to grow to $42.81 billion in 2030 at a compound annual growth rate (CAGR) of 8.8% • Growth Driver: Cardiovascular Disease Surge Spurs Growth In Active Implantable Medical Devices Market • Market Trend: Invibio launches implantable PEEK filament for 3D printing • North America was the largest region and fastest growing region.

What Is Covered Under Active Implantable Medical Devices Market?

An active implantable medical device (AIMD) is a medical device that is completely or partially implanted into the human body for diagnostic or therapeutic reasons. Active implantable medical devices are designed to remain in place. The main products of active implantable medical devices include cardiac pacemakers, implantable cardioverter defibrillators (ICD), nerve simulators, cochlear implants, ventricular assist devices, and others. Implantable cardioverter-defibrillator (ICD) refers to a small battery-powered device that is implanted in the chest to detect and stop abnormal heartbeats. They are used in various applications such as cardiovascular, neurological, and hearing impairment, and others for use by end-users such as hospitals, specialty clinics, and ambulatory surgical centers.

What Is The Active Implantable Medical Devices Market Growth Forecast?

The active implantable medical devices market size is expected to see strong growth in the next few years. It will grow to $42.81 billion in 2030 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to expansion of remote patient monitoring solutions, rising demand for personalized implantable therapies, increasing integration of ai-enabled diagnostics, growth in aging population requiring chronic care, advancements in wireless power and communication technologies. Major trends in the forecast period include increasing integration of smart and connected implantable devices, rising adoption of miniaturized electronic components, growing use of data-driven therapeutic monitoring, expansion of long-term implantable therapies, enhanced focus on device longevity and reliability.

Global Active Implantable Medical Devices Market Segmentation

1) By Product Type: Cardiac Pacemakers, Implantable Cardioverter Defibrillators (ICD), Nerve Simulators, Cochlear Implants, Ventricular Assist Devices, Other Products 2) By Application: Cardiovascular, Neurological, Hearing Impairment, Other Applications 3) By End User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers Subsegments: 1) By Cardiac Pacemakers: Single Chamber Pacemakers, Dual Chamber Pacemakers, Biventricular Pacemakers 2) By Implantable Cardioverter Defibrillators (ICD): Transvenous ICDs, Subcutaneous ICDs 3) By Nerve Stimulators: Spinal Cord Stimulators, Peripheral Nerve Stimulators, Deep Brain Stimulators 4) By Cochlear Implants: Single-Electrode Cochlear Implants, Multichannel Cochlear Implants 5) By Ventricular Assist Devices: Left Ventricular Assist Devices (LVAD), Right Ventricular Assist Devices (RVAD), Bi-Ventricular Assist Devices (BiVAD) 6) By Other Products: Neurostimulators for Pain Management, Implantable Drug Delivery Systems, Implantable Blood Pressure Monitors

What Is The Driver Of The Active Implantable Medical Devices Market?

An increasing number of cardiovascular diseases is expected to propel the growth of the active implantable medical devices market going forward. Cardiovascular disease (CVD) refers to any condition that affects the heart or blood vessels. It is generally associated with the formation of fatty deposits inside the arteries (atherosclerosis) and an increased risk of blood clots. Active implantable medical devices are used to regulate or monitor irregular heartbeats in people who have specific heart rhythm problems or heart failure. The rise in the geriatric population has favored the demand for active implantable medical devices. For instance, in September 2025, according to the British Heart Foundation, a UK-based charity, across the UK, more than 7.6 million people—over 4 million men and more than 3.6 million women—are living with cardiovascular disease, and projections indicate that, driven by an aging population and improved survival rates, the number of affected individuals may rise by around 1 million by 2030 and by approximately 2 million by 2040. Therefore, the increase in cardiovascular diseases is driving the growth of the active implantable medical devices industry.

Key Players In The Global Active Implantable Medical Devices Market

Major companies operating in the active implantable medical devices market are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, BIOTRONIK SE & Co KG, LivaNova PLC, Cochlear Limited, MED‑EL Medical Electronics, Sonova Holding AG, NeuroPace Inc, NEVRO Corp, Axonics Inc, Aleva Neurotherapeutics SA, MicroTransponder Inc, Shree Pacetronix, Berlin Heart GmbH, Jarvik Heart Inc, Blackrock Neurotech, Nurotron Biotechnology Co Ltd, CARMAT SA, Precision Neuroscience, Pins Medical, Lepu Medical Technology Co Ltd, LifeTech Scientific

Global Active Implantable Medical Devices Market Trends and Insights

Major Companies operating in the active implantable medical device market are focusing on developing technological advancement such as implantable PEEK filament to enhance customization, improve patient outcomes, and streamline production processes. Implantable PEEK filament is a specialized material designed for creating medical implants using additive manufacturing techniques. For instance, in March 2023, Invibio, a U.K.-based provider of high-performance implantable biomaterials launched PEEK-OPTIMA AM filament. PEEK-OPTIMA AM filament is made from implantable polyetheretherketone (PEEK) filament known for its biocompatibility and mechanical strength, making it suitable for implantable medical devices. This new filament is optimized for fused filament fabrication (FFF) and aims to enhance the production of medical devices. It is specifically designed for 3D printing applications in the medical field.

What Are Latest Mergers And Acquisitions In The Active Implantable Medical Devices Market?

In December 2023, TekniPlex Healthcare, a U.S-based company that manufactures medical device components acquired Seisa Medical for an undisclosed amount. With this acquisition, TekniPlex strengthens its medical technology solutions platforms particularly in the minimally invasive and interventional therapy sectors. Seisa Medical, a U.S-based company that manufactures active implantabke medical devices.

Regional Outlook

North America was the largest region in the active implantable medical devices market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Active Implantable Medical Devices Market?

The active implanted medical devices market consists of sales of active implanted medical devices with components such as battery packs, controllers, implant kits, leads, programmers, and refill kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.